Twitter feed

The #ASCOBT23 program is now available! See which global thought leaders are joining us in Yokohama this August for a one-of-a-kind meeting exploring innovations in clinical cancer care.

Explore the program ➡️ https://t.co/HdyUjS5fMe @JSMO_official @lillian_siu

How to Design a Successful Career Path in Cancer Research: In this #AACR23 career session (Sunday, April 16), early-career scientists will learn strategies to enhance the probability of success in the pursuit of their first independent research position. https://t.co/cHnfvHsxf7

The AACR is the Founding Organizer of the Rally for Medical Research, which marked its 10th anniversary in 2022 and brought more than 250 advocates to Washington, DC, to advocate for biomedical research. Learn more in the AACR Annual Impact Report:

The Winn CDA is a 2-year program offering training and resources to help early-stage investigators become independent clinical trial investigators with both community engagement and research skills. Register for the info session on March 28 to learn more: https://t.co/cwsVptWy1o

Draft guidance from @FDAOncology and a new federal law require trial sponsors to develop Diversity Action Plans to expand the representation of patient populations. An #AACR23 session on Monday, April 17 will highlight progress. https://t.co/OMT7KKGjQW

Find your next job at the Cancer and Biomedical Research Career Fair during the AACR Annual Meeting 2023, Saturday, April 15 in Orlando, FL. Submit your CV/resume to CancerCareers today and attend the fair for the chance to win great prizes.

Recent publications

Targeting TBK1 to overcome resistance to cancer immunotherapy.
Nature. 2023 Mar.

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C.
N Engl J Med. 2023 Jan 5.

All publications



Target identification and validation image
Target identification and validation
Photo of scientist carefully adding fluid to multiple test tubes
Drug discovery and development
Photo of Belfer Center researcher working at computer
Clinical science and correlatives

Strategic alliances

Graphic showing circular relationship of research, medicine, and industry

Our strategic alliances drive research innovations and lead to improved therapies to benefit cancer patients

Collaborate with us

Our people

Background image is a collage of photos showing Belfer Center members
Our team
Our culture
Background image is a collage of photos showing Belfer Center members

Donor highlight

Robert and Renée Belfer’s transformative cumulative Dana-Farber investment of more than $25 million launched the Robert A. and Renée E. Belfer Center for Applied Cancer Science. Their generosity enabled the Belfer Center to integrate its scientific teams, produce innovative cancer models, partner with industry leaders, and accelerate the development of revolutionary therapies to treat cancer. We are grateful for their vision and incredible support.

Photo of donors, Mr. and Mrs Belfer
Go to Top